Institutional Ownership Day One Biopharmaceuticals, Inc. (DAWN)
This table provides information about the institutional ownership of Day One Biopharmaceuticals, Inc. (DAWN). We have compiled data on the 188 institutions that hold shares in the stock, with a total of 69.3 Million shares, which have been reported (via 13F filing form) to have a value of $518 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Hsbc Holdings PLC
London, X0 |
Aug 13, 2025 Q2 2025 |
131,668
shares
|
$975,659
0.0% of portfolio
|
Q2 2025
Added 162.41%
|
|
|
Neos Investment Management LLC
Westport, CT |
Aug 13, 2025 Q2 2025 |
124,310
shares
|
$921,137
0.01% of portfolio
|
Q2 2025
Added 36.42%
|
|
|
Tema Etfs LLC
New York, NY |
Aug 13, 2025 Q2 2025 |
124,310
shares
|
$921,137
0.21% of portfolio
|
Q2 2025
Added 36.42%
|
|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
116,060
shares
|
$860,004
0.0% of portfolio
|
Q2 2025
Added 41.81%
|
|
|
Trexquant Investment LP
Stamford, CT |
Aug 12, 2025 Q2 2025 |
115,427
shares
|
$855,314
0.01% of portfolio
|
Q2 2025
Reduced 43.63%
|
|
|
Macquarie Group LTD
Australia, C3 |
Aug 14, 2025 Q2 2025 |
110,000
shares
|
$815,100
0.0% of portfolio
|
Q3 2024
Reduced 0.55%
|
|
|
Citigroup Inc
|
Aug 11, 2025 Q2 2025 |
108,371
shares
|
$803,029
0.0% of portfolio
|
Q2 2025
Reduced 34.19%
|
|
|
Swiss National Bank
Zurich, V8 |
May 12, 2025 Q1 2025 |
107,500
shares
|
$796,575
0.0% of portfolio
|
Q1 2025
Reduced 8.74%
|
|
|
Ubs Oconnor LLC
Chicago, IL |
Aug 14, 2025 Q2 2025 |
107,249
shares
|
$794,715
0.03% of portfolio
|
Q2 2025
Reduced 5.3%
|
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
100,516
shares
|
$744,823
0.0% of portfolio
|
Q2 2025
Reduced 52.84%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
100,502
shares
|
$744,719
0.0% of portfolio
|
Q2 2025
Reduced 7.43%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
99,590
shares
|
$737,961
0.01% of portfolio
|
Q2 2025
Added 51.99%
|
|
|
Rafferty Asset Management, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
98,691
shares
|
$731,300
0.0% of portfolio
|
Q2 2025
Reduced 17.18%
|
|
|
Hennion & Walsh Asset Management, Inc.
|
Aug 07, 2025 Q2 2025 |
96,821
shares
|
$717,443
0.03% of portfolio
|
Q2 2025
Reduced 29.82%
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
89,475
shares
|
$663,009
0.0% of portfolio
|
Q2 2025
Reduced 27.95%
|
|
|
Los Angeles Capital Management LLC
|
Aug 06, 2025 Q2 2025 |
82,257
shares
|
$609,524
0.0% of portfolio
|
Q2 2025
Added 49.77%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Aug 14, 2025 Q2 2025 |
81,303
shares
|
$602,455
0.0% of portfolio
|
Q2 2025
Reduced 2.13%
|
|
|
Catalytic Wealth Ria, LLC
Cambridge, MA |
Jul 17, 2025 Q2 2025 |
80,000
shares
|
$592,800
0.04% of portfolio
|
Q2 2025
New holding
|
|
|
Dark Forest Capital Management LP
Weston, CT |
Aug 14, 2025 Q2 2025 |
78,422
shares
|
$581,107
0.02% of portfolio
|
Q2 2025
New holding
|
|
|
Wells Fargo & Company
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
72,567
shares
|
$537,721
0.0% of portfolio
|
Q2 2025
Added 35.14%
|
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2025 Q2 2025 |
68,507
shares
|
$507,636
0.0% of portfolio
|
Q2 2025
Added 47.57%
|
|
|
Alliancebernstein L.P.
New York, NY |
Aug 14, 2025 Q2 2025 |
67,790
shares
|
$502,323
0.0% of portfolio
|
Q1 2025
Reduced 0.31%
|
|
|
Virtus Investment Advisers, Inc.
Hartford, CT |
Aug 13, 2025 Q2 2025 |
66,427
shares
|
$492,224
0.15% of portfolio
|
Q2 2025
Added 136.99%
|
|
|
Gsa Capital Partners LLP
London, X0 |
Jul 22, 2025 Q2 2025 |
63,546
shares
|
$470,875
0.03% of portfolio
|
Q2 2025
Added 45.4%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
61,536
shares
|
$455,981
0.0% of portfolio
|
Q1 2025
Added 1.84%
|